FDA recommends against off-label sildenafil use in children

被引:0
|
作者
机构
关键词
Adult Patient; Paediatric Patient; Pulmonary Hypertension; Adult Male; Dose Regimen;
D O I
10.2165/00128415-201214180-00004
中图分类号
学科分类号
摘要
引用
收藏
页码:2 / 2
相关论文
共 50 条
  • [31] Off-Label Topical Calcineurin Inhibitor Use in Children
    Manthripragada, Angelika D.
    Pinheiro, Simone P.
    MaCurdy, Thomas E.
    Saneinejad, Shahin
    Worrall, Chris M.
    Kelman, Jeffrey A.
    Graham, David J.
    PEDIATRICS, 2013, 132 (05) : E1327 - E1332
  • [32] FDA off-track on off-label drug promotion
    不详
    LANCET, 2007, 370 (9604): : 1976 - 1976
  • [33] Off-label use and G-BA. Legal framework for off-label use
    Brucklacher, U.
    Brockmeyer, N. H.
    Riedel, C.
    HAUTARZT, 2013, 64 (10): : 736 - 742
  • [34] Off-Label Antidepressant Use
    Schaefer, Wiebke
    Kollhorst, Bianca
    Reinders, Tammo
    Riedel, Oliver
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 465 - 466
  • [37] Off-label use in psychiatry
    Weih, M.
    Thurauf, N.
    Bleich, S.
    Kornhuber, J.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2008, 76 (01) : 7 - 13
  • [38] Indian experts protest, against off-label drug use
    Sharma, DC
    LANCET, 2004, 363 (9418): : 1372 - 1372
  • [39] Off-Label Medication Use
    Howland, Robert H.
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2012, 50 (09) : 11 - 13
  • [40] Off-label use of alitretinoin
    Fritz, K.
    Tiplica, G. S.
    Salavastru, C.
    Onder, M.
    HAUTARZT, 2013, 64 (10): : 748 - 751